Skip to Main Content

Paper Details

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail
353
2018
CV disease, DPP4, GLP-1, HF, HFpEF, HFrEF, Heart Failure, SGLT2, Sulphonylureas, T2DM, Thiazolidinediones, Type 2 diabetes mellitus, arterial hypertension, canagliflozin, coronary artery disease, dipeptidyl peptidase-4, empagliflozin, glucagon-like preptide-1, glucose, heart failure, insulin, metformin, patients, pioglitazone, rosiglitazone, saxagliptin, sodium, sodium-glucose co-transporter-2, type 2 diabetes mellitus
Author NameAffiliation
Gerasimos FilippatosNational and Kapodistrian University of Athens Medical School, Athens University Hospital "Attikon"
Michel KomajdaInstitute of Cardiometabolism and Nutrition (ICAN), Pierre et Marie Curie University, La Pitie-Salpetriere Hospital
Rudolf A de BoerUniversity of Groningen, University Medical Centre Groningen
Alexandre MebazaaUniversity Paris Diderot, University Hospitals Saint Louis-Lariboisiere
  • 1 - 4

Datasets

Release 1.2